Cite
HARVARD Citation
Yu, L. et al. (2020). Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of oncology. p. . [Online].